Efficacy of Procainamide and Lidocaine in Terminating Sustained Monomorphic Ventricular Tachycardia - Retrospective Case Series -
-
- Komura Satoru
- Division of Cardiology, Niigata University Graduate School of Medical and Dental Science
-
- Chinushi Masaomi
- Division of Cardiology, Niigata University Graduate School of Medical and Dental Science
-
- Furushima Hiroshi
- Division of Cardiology, Niigata University Graduate School of Medical and Dental Science
-
- Hosaka Yukio
- Division of Cardiology, Niigata University Graduate School of Medical and Dental Science
-
- Izumi Daisuke
- Division of Cardiology, Niigata University Graduate School of Medical and Dental Science
-
- Iijima Kenichi
- Division of Cardiology, Niigata University Graduate School of Medical and Dental Science
-
- Watanabe Hiroshi
- Division of Cardiology, Niigata University Graduate School of Medical and Dental Science
-
- Yagihara Nobue
- Division of Cardiology, Niigata University Graduate School of Medical and Dental Science
-
- Aizawa Yoshifusa
- Division of Cardiology, Niigata University Graduate School of Medical and Dental Science
書誌事項
- タイトル別名
-
- – Retrospective Case Series –
この論文をさがす
説明
Background: The efficacy of antiarrhythmic drugs in terminating sustained monomorphic ventricular tachycardia (SMVT) was assessed in a retrospective manner to provide a basis for recommending their use. Methods and Results: The 90 patients were included in this study to evaluate the efficacy to terminate SMVT using procainamide or lidocaine. All patients were alert and responsive. The mean systolic blood pressure was 91±25 mmHg (range, 40–150 mmHg). SMVT was diagnosed from ECG recordings and later in an electrophysiologic study. VTs with a cycle length of 329±55 and 324±61 ms were treated with the mean doses of 358±50 mg and 81±30 mg of procainamide and lidocaine and were terminated in 53/70 (75.7%) and in 7/20 (35.0%) respectively. The drugs were discontinued if there was no rise in blood pressure after slowing of the tachycardia rate or if there were signs of impending deterioration in consciousness. Though procainamide was effective, blood pressure was often low and DC shock should be available at all times during administration of the drug. Conclusions: Procainamide, the relatively older drug, was more effective than lidocaine in terminating SMVT associated with structural heart diseases. This is a retrospective analysis but can form the basis for formulating guidelines for initial management of SMVT. (Circ J 2010; 74: 864 - 869)<br>
収録刊行物
-
- Circulation Journal
-
Circulation Journal 74 (5), 864-869, 2010
一般社団法人 日本循環器学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282680079463424
-
- NII論文ID
- 10026473344
-
- NII書誌ID
- AA11591968
-
- ISSN
- 13474820
- 13469843
-
- PubMed
- 20339190
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
- OpenAIRE
-
- 抄録ライセンスフラグ
- 使用不可